Advertisement

International Ophthalmology

, Volume 39, Issue 2, pp 317–333 | Cite as

Presumed tuberculous uveitis in a university-based tertiary referral center in Saudi Arabia

  • Awad Al-Qarni
  • Marwan A. Abouammoh
  • Abdullah N. Almousa
  • Ahmed Mousa
  • Ahmed M. Abu El-AsrarEmail author
Original Paper

Abstract

Purpose

To describe clinical characteristics and outcomes of treatment in patients with presumed tuberculous uveitis (PTU).

Methods

All patients diagnosed with PTU between January 1996 and March 2013 were reviewed. The diagnosis was made when clinical findings were consistent with possible intraocular tuberculosis, strongly positive purified protein derivative (PPD) skin test result, and response to anti-tuberculous therapy with no other cause of uveitis as suggested by history, symptoms, or ancillary testing.

Results

Ninety patients (141 eyes) were identified. There were 43 males (47.3%) and 47 females (52.7%). Mean age was 48.2 ± 14.4 years. Mean duration of symptoms prior to presentation was 6.7 ± 8.3 months. Ten eyes (7.1%) had anterior uveitis, 18 eyes (12.8%) had intermediate uveitis, 34 eyes (24.1%) had posterior uveitis, and 79 eyes (56%) had panuveitis. Macular edema was present in 33.3% of the eyes at presentation. All patients received anti-tuberculous therapy and systemic corticosteroids. Mean follow-up after completion of therapy was 36 ± 2.5 months. Only 2 eyes developed recurrent inflammation after treatment completion. At last follow-up, all eyes showed resolution of inflammation, associated with significant improvement in visual acuity. There was a significant positive correlation between initial and final VA. Eyes that had macular edema at presentation showed a significant reduction in central macular thickness at final follow-up.

Conclusions

There is delay in presentation of patients with PTU. The most common anatomic diagnosis was panuveitis. Treatment with anti-tuberculous therapy combined with systemic corticosteroids resulted in resolution of inflammation and macular edema with significant improvement in visual acuity.

Keywords

Uveitis Tuberculosis Macular edema Visual acuity 

Notes

Acknowledgements

The authors thank Ms. Connie Unisa-Marfil for secretarial assistance. This work was supported by King Saud University through Vice Deanship of Research Chair (Dr. Nasser Al-Rashid Research Chair in Ophthalmology [AMA]), Riyadh, Saudi Arabia.

Compliance with ethical standards

Conflict of interest

The authors declare that they do not have any conflict of interest on the content of manuscript and study undertaken.

References

  1. 1.
    Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677–686CrossRefGoogle Scholar
  2. 2.
    World Health Organisation. Tuberculosis Fact Sheet 2015. World Health Organization; 2016. http://www.who.int/mediacentre/factsheets/fs104/en/. Accessed 21 November 2016
  3. 3.
    Centers for Disease Control (USA). Tuberculosis—Data and Statistics 2015. http://www.cdc.gov/tb/statistics/default.htm. Accessed 21 November 2017
  4. 4.
    Al-Mezaine HS, Kangave D, Abu El-Asrar AM (2010) Patterns of Uveitis in patients admitted to a university hospital in Riyadh, Saudi Arabia. Ocul Immunol Inflamm 18:424–431CrossRefGoogle Scholar
  5. 5.
    Al Dhahri H, Al Rubaie K, Hemachandran S et al (2015) Patterns of uveitis in a university-based tertiary referral center in Riyadh, Saudi Arabia. Ocul Immunol Inflamm 23:311–319CrossRefGoogle Scholar
  6. 6.
    Amin RM, Goweida M, Bedda A, Kamel A, Radwan A (2016) Clinical patterns and causes of intraocular inflammation in a uveitis patient cohort from Egypt. Ocul Immunol Inflamm.  https://doi.org/10.1080/09273948.2016.1236972 Google Scholar
  7. 7.
    Nguyen M, Siak J, Chee SP, Diem VQ (2016) The spectrum of uveitis in Southern vietnam. Ocul Immunol Inflamm.  https://doi.org/10.1080/09273948.2016.1231826 Google Scholar
  8. 8.
    Kianersi F, Mohammadi Z, Ghanbari H, Ghoreyshi SM, Karimzadeh H, Soheilian M (2015) Clinical patterns of uveitis in an iranian tertiary eye-care center. Ocul Immunol Inflamm 23:278–282CrossRefGoogle Scholar
  9. 9.
    Vos AG, Wassenberg MWM, de Hoog J, Oosterheert JJ (2013) Diagnosis and treatment of tuberculous uveitis in a low endemic setting. Int J Infect Dis 17:e993–e999CrossRefGoogle Scholar
  10. 10.
    Llorenç Bellés V, Adán Civera A, Espinosa Garriga G et al (2012) Uveitis diagnosis characterization at a referral centre in the area of Barcelona, Spain. Med Clin (Barc) 138:277–282CrossRefGoogle Scholar
  11. 11.
    Ducommun M-A, Eperon S, Khonkarly MB, Cavassini M, Guex-Crosier Y (2012) Long-term close follow-up of chorioretinal lesions in presumed ocular tuberculosis. Eur J Ophthalmol 22:195–202CrossRefGoogle Scholar
  12. 12.
    Sanghvi C, Bell C, Woodhead M, Hardy C, Jones N (2011) Presumed tuberculous uveitis: diagnosis, management, and outcome. Eye 25:475–480.  https://doi.org/10.1038/eye.2010.235 CrossRefGoogle Scholar
  13. 13.
    Kazokoglu H, Onal S, Tugal-Tutkun I et al (2008) Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol 15:285–293CrossRefGoogle Scholar
  14. 14.
    Pathanapitoon K, Kunavisarut P, Ausayakhun S, Sirirungsi W, Rothova A (2008) Uveitis in a tertiary ophthalmology centre in Thailand. Br J Ophthalmol 92:474–478CrossRefGoogle Scholar
  15. 15.
    Khairallah M, Ben Yahia S, Ladjimi A et al (2007) Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye 21:33–39CrossRefGoogle Scholar
  16. 16.
    Rathinam SR, Namperumalsamy P (2007) Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol 55:173–183CrossRefGoogle Scholar
  17. 17.
    Yang P, Zhang Z, Zhou H et al (2005) Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 30:943–948CrossRefGoogle Scholar
  18. 18.
    Sengün A, Karadağ R, Karakurt A, Saricaoğlu MS, Abdik O, Hasiripi H (2005) Causes of uveitis in a referral hospital in Ankara, Turkey. Ocul Immunol Inflamm 13:45–50CrossRefGoogle Scholar
  19. 19.
    Soheilian M, Heidari K, Yazdani S, Shahsavari M, Ahmadieh H, Dehghan M (2004) Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm 12:297–310CrossRefGoogle Scholar
  20. 20.
    Singh R, Gupta V, Gupta A (2004) Pattern of uveitis in a referral eye clinic in north India. Indian J Ophthalmol 52:121–125Google Scholar
  21. 21.
    Wakabayashi T, Morimura Y, Miyamoto Y, Okada AA (2003) Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm 11:277–286CrossRefGoogle Scholar
  22. 22.
    Islam SMM, Tabbara KF (2002) Causes of uveitis at the eye center in Saudi Arabia: a retrospective review. Ophthalmic Epidemiol 9:239–249CrossRefGoogle Scholar
  23. 23.
    Mercanti A, Parolini B, Bonora A, Lequaglie Q, Tomazzoli L (2001) Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. Acta Ophthalmol Scand 79:64–68CrossRefGoogle Scholar
  24. 24.
    Kaimbo Wa Kimbo D, Bifuko A, Dernouchamps JP, Missotten L (1998) Chronic uveitis in Kinshasa (D R Congo). Bull Soc Belge Ophtalmol 270:95–100Google Scholar
  25. 25.
    Kotake S, Furudate N, Sasamoto Y, Yoshikawa K, Goda C, Matsuda H (1997) Characteristics of endogenous uveitis in Hokkaido, Japan. Graefes Arch Clin Exp Ophthalmol 235:5–9CrossRefGoogle Scholar
  26. 26.
    Merrill PT, Kim J, Cox TA, Betor CC, McCallum RM, Jaffe GJ (1997) Uveitis in the southeastern United States. Curr Eye Res 16:865–874CrossRefGoogle Scholar
  27. 27.
    Rodriguez A, Calonge M, Pedroza-Seres M, et al (1996) Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol (Chicago, Ill 1960) 114:593–599Google Scholar
  28. 28.
    Thean LH, Thompson J, Rosenthal AR (1996) A uveitis register at the Leicester royal Infirmary. Ophthalmic Epidemiol 3:151–158CrossRefGoogle Scholar
  29. 29.
    Smit RL, Baarsma GS (1995) Epidemiology of uveitis. Curr Opin Ophthalmol 6:57–61CrossRefGoogle Scholar
  30. 30.
    Weiner A, BenEzra D (1991) Clinical patterns and associated conditions in chronic uveitis. Am J Ophthalmol 112:151–158CrossRefGoogle Scholar
  31. 31.
    Palmares J, Coutinho MF, Castro-Correia J (1990) Uveitis in northern Portugal. Curr Eye Res 9(Suppl):31–34CrossRefGoogle Scholar
  32. 32.
    Rosen PH, Spalton DJ, Graham EM (1990) Intraocular tuberculosis. Eye 4:486–492CrossRefGoogle Scholar
  33. 33.
    Sheu SJ, Shyu JS, Chen LM, Chen YY, Chirn SC, Wang JS (2001) Ocular manifestations of tuberculosis. Ophthalmology 108:1580–1585CrossRefGoogle Scholar
  34. 34.
    Sakai J, Matsuzawa S, Usui M, Yano I (2001) New diagnostic approach for ocular tuberculosis by ELISA using the cord factor as antigen. Br J Ophthalmol 85:130–133CrossRefGoogle Scholar
  35. 35.
    Al-Mezaine HS, Al-Muammar A, Kangave D, Abu El-Asrar AM (2008) Clinical and optical coherence tomographic findings and outcome of treatment in patients with presumed tuberculous uveitis. Int Ophthalmol 28:413–423CrossRefGoogle Scholar
  36. 36.
    Sarvananthan N, Wiselka M, Bibby K (1998) Intraocular tuberculosis without detectable systemic infection. Arch Ophthalmol (Chicago, III 1960) 116:1386–1388Google Scholar
  37. 37.
    Cimino L, Herbort CP, Aldigeri R, Salvarani C, Boiardi L (2009) Tuberculous uveitis, a resurgent and underdiagnosed disease. Int Ophthalmol 29:67–74CrossRefGoogle Scholar
  38. 38.
    Morimura Y, Okada AA, Kawahara S et al (2002) Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology 109:851–857CrossRefGoogle Scholar
  39. 39.
    Wolfensberger TJ, Piguet B, Herbort CP (1999) Indocyanine green angiographic features in tuberculous chorioretinitis. Am J Ophthalmol 127:350–353CrossRefGoogle Scholar
  40. 40.
    Abu El-asrar A, Abouammoh M, Al-mezaine HS (2009) Tuberculous uveitis. Middle East Afr J Ophthalmol 16:188–201Google Scholar
  41. 41.
    Alvarez S, McCabe WR (1984) Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Med 63:25–55CrossRefGoogle Scholar
  42. 42.
    Schlaegel TF, Weber JC (1969) Double-blind therapeutic trial of isoniazid in 344 patients with uveitis. Br J Ophthalmol 53:425–427CrossRefGoogle Scholar
  43. 43.
    Woods AC, Wood R, Senterfit LB (1958) Studies in experimental ocular tuberculosis. XVIII. The effect of cortisone combined with specific antibacterial therapy on experimental ocular tuberculosis in the immune-allergic rabbit. AMA Arch Ophthalmol 59:559–578CrossRefGoogle Scholar
  44. 44.
    Hamade IH, Tabbara KF (2010) Complications of presumed ocular tuberculosis. Acta Ophthalmol 88:905–909CrossRefGoogle Scholar
  45. 45.
    Gupta V, Gupta A, Rao NA (2007) Intraocular Tuberculosis—An Update. Surv Ophthalmol 52:561–587CrossRefGoogle Scholar
  46. 46.
    Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509–516Google Scholar
  47. 47.
    Rowland K, Guthmann R, Jamieson B, Malloy D (2006) Clinical inquiries. How should we manage a patient with a positive PPD and prior BCG vaccination? J Fam Pract 55:718–720Google Scholar
  48. 48.
    Manousaridis K, Ong E, Stenton C, Gupta R, Browning AC, Pandit R (2013) Clinical presentation, treatment, and outcomes in presumed intraocular tuberculosis: experience from Newcastle upon Tyne, UK. Eye (Lond) 27:480–486.  https://doi.org/10.1038/eye.2013.11 CrossRefGoogle Scholar
  49. 49.
    Llorenç V, González-Martin J, Keller J et al (2013) Indirect supportive evidence for diagnosis of tuberculosis-related uveitis: from the tuberculin skin test to the new interferon gamma release assays. Acta Ophthalmol 91:99–107.  https://doi.org/10.1111/j.1755-3768.2012.02564.x CrossRefGoogle Scholar
  50. 50.
    Mao Y, Peng XY, You QS, Wang H, Zhao M, Jonas JB (2014) Tuberculous uveitis in China. Acta Ophthalmol 92:393–397.  https://doi.org/10.1111/aos.12351 CrossRefGoogle Scholar
  51. 51.
    Basu S, Monira S, Modi RR et al (2014) Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis. J Ophthalmic Inflamm Infect 4:3.  https://doi.org/10.1186/1869-5760-4-3 CrossRefGoogle Scholar
  52. 52.
    La Distia Nora R, Van Velthoven MEJ, Ten Dam-Van Loon NH et al (2014) Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol 157:754–761CrossRefGoogle Scholar
  53. 53.
    Khochtali S, Gargouri S, Abroug N et al (2015) The spectrum of presumed tubercular uveitis in Tunisia, North Africa. Int Ophthalmol 35:663–671Google Scholar
  54. 54.
    Gunasekeran DV, Gupta B, Cardoso J, Pavesio CE, Agrawal R (2017) Visual morbidity and ocular complications in presumed intraocular tuberculosis: an analysis of 354 cases from a non-endemic population. Ocul Immunol Inflamm.  https://doi.org/10.1080/09273948.2017.1296580 Google Scholar
  55. 55.
    Gineys R, Bodaghi B, Carcelain G et al (2011) QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation. Am J Ophthalmol 152(433–440):e1Google Scholar
  56. 56.
    Gupta V, Arora S, Gupta A, Ram J, Bambery P, Sehgal S (1998) Management of presumed intraocular tuberculosis: possible role of the polymerase chain reaction. Acta Ophthalmol Scand 76:679–682CrossRefGoogle Scholar
  57. 57.
    Bansal R, Gupta A, Gupta V, Dogra MR, Sharma A, Bambery P (2012) Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis. Ophthalmology 119:2334–2342CrossRefGoogle Scholar
  58. 58.
    El-Asrar AMA, Al-Kharashi SA (2002) Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales’ disease). Br J Ophthalmol 86:1248–1251CrossRefGoogle Scholar
  59. 59.
    Helm CJ, Holland GN (1993) Ocular tuberculosis. Surv Ophthalmol 38:229–256CrossRefGoogle Scholar
  60. 60.
    Vasconcelos-Santos DV, Rao PK, Davies JB, Sohn EH, Rao NA (2010) Clinical features of tuberculous serpiginouslike choroiditis in contrast to classic serpiginous choroiditis. Arch Ophthalmol 128:853–858CrossRefGoogle Scholar
  61. 61.
    Massaro D, Katz S, Sachs M (1964) Choroidal tubercles. a clue to hematogenous tuberculosis. Ann Intern Med 60:231–241CrossRefGoogle Scholar
  62. 62.
    Cangemi FE, Friedman AH, Josephberg R (1980) Tuberculoma of the choroid. Ophthalmology 87:252–258CrossRefGoogle Scholar
  63. 63.
    Mansour AM, Haymond R (1990) Choroidal tuberculomas without evidence of extraocular tuberculosis. Graefes Arch Clin Exp Ophthalmol 228:382–383CrossRefGoogle Scholar
  64. 64.
    Alaraj AM, Al-Dhibi H, Al-Mezaine HS, Abu El-Asrar AM (2013) Solitary presumed choroidal tuberculomas masquerading as choroidal tumors. Saudi Med J 34:86–90Google Scholar
  65. 65.
    Lardenoye CWTA, van Kooij B, Rothova A (2006) Impact of Macular Edema on Visual Acuity in Uveitis. Ophthalmology 113:1446–1449CrossRefGoogle Scholar
  66. 66.
    Babu K, Satish V, Prakash O, Subbakrishna DK, Murthy KR (2009) Role of the mantoux test and treatment with antitubercular therapy in a South Indian patient population of presumed intraocular tuberculosis. Ocul Immunol Inflamm 17:307–311CrossRefGoogle Scholar
  67. 67.
    Ang M, Wong WL, Li X, Chee S-P (2013) Interferon γ release assay for the diagnosis of uveitis associated with tuberculosis: a Bayesian evaluation in the absence of a gold standard. Br J Ophthalmol 97:1062–1067CrossRefGoogle Scholar
  68. 68.
    Bodaghi B, LeHoang P (2000) Ocular tuberculosis. Curr Opin Ophthalmol 11:443–448CrossRefGoogle Scholar
  69. 69.
    Gupta V, Gupta A, Arora S, Bambery P, Dogra MR, Agarwal A (2003) Presumed tubercular serpiginouslike choroiditis: clinical presentations and management. Ophthalmology 110:1744–1749CrossRefGoogle Scholar
  70. 70.
    Gupta A, Gupta V, Arora S, Dogra MR, Bambery P (2001) PCR-positive tubercular retinal vasculitis: clinical characteristics and management. Retina 21:435–444CrossRefGoogle Scholar
  71. 71.
    Bansal R, Gupta A, Gupta V, Dogra MR, Bambery P, Arora SK (2008) Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol 146(772–779):e2Google Scholar
  72. 72.
    Agarwal A, Handa S, Aggarwal K, Sharma M, Singh R, Sharma A, Agrawal R, Sharma K, Gupta V (2017) The role of dexamethasone implant in the management of tubercular uveitis. Ocul Immunol Inflamm.  https://doi.org/10.1080/09273948.2017.1400074. [Epub ahead of print]
  73. 73.
    Jain L, Panda KG, Basu S (2017) Clinical outcomes of adjunctive sustained-release intravitreal dexamethasone implants in tuberculosis-associated multifocal serpigenoid choroiditis. Ocul Immunol Inflamm.  https://doi.org/10.1080/09273948.2017.1383446. [Epub ahead of print]
  74. 74.
    Rao NA, Saraswathy S, Smith RE et al (2006) Tuberculous uveitis: distribution of Mycobacterium tuberculosis in the Retinal Pigment Epithelium. Arch Ophthalmol 124:1777CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Ophthalmology, College of MedicineKing Saud UniversityRiyadhSaudi Arabia
  2. 2.King Khaled Eye Specialist HospitalRiyadhSaudi Arabia
  3. 3.Dr. Nasser Al-Rashid Research Chair in Ophthalmology, King Saud UniversityRiyadhSaudi Arabia

Personalised recommendations